Every Form 4 that DaVita Inc. (DVA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DVA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DVA filings page.
DaVita Inc. (DVA) director Jason M. Hollar reported an acquisition of company stock through an equity grant. On 2026-08-15, he received 278 shares of DaVita common stock at a reported price of $0.00 per share, increasing his directly held position to 6,883 shares of common stock after the transaction.
DAVITA INC. (symbol: DVA) is the issuer of record for a Form 4 filing submitted to the SEC.
DaVita Inc. (DVA) director Adam H. Schechter reported an automatic equity acquisition. He received a grant of 278 shares of Common Stock on August 15, 2026, recorded at a price of $0.00 per share as an award, bringing his direct holdings to 5,970 shares after the transaction.
DAVITA INC. (DVA) reported that a board director received an equity grant of common stock. Reporting person Gregory J. Moore was awarded 278 shares of DaVita common stock on August 15, 2026, at a stated price of $0.00 per share, increasing his directly held position to 8,091 shares after the transaction. The filing indicates this award was a grant, award, or other acquisition of stock and that it was not executed under a Rule 10b5-1 trading plan.
DaVita Inc. (DVA) reported an insider equity award to board member Dennis W. Pullin. On 2026-08-15, Pullin received a grant of 278 shares of Common Stock at a stated price of $0.00 per share, classified as a grant, award, or other acquisition. Following this award, his directly held Common Stock position increased to 2,949 shares.
DAVITA INC. (symbol: DVA) is the issuer of record for a Form 4 filing submitted to the SEC.
DAVITA INC. (symbol: DVA) is the issuer of record for a Form 4 filing submitted to the SEC.
DaVita Inc. (DVA) reported an insider equity award to board member Phyllis R. Yale. On 2026-08-15 she received a grant of 278 shares of Common Stock at a stated price of $0.00 per share, classified as a grant/award acquisition. Following this award, she directly holds 9,803 DaVita common shares. No sales or derivative transactions were reported in this filing.
Berkshire Hathaway Inc. and Warren E. Buffett, as 10% owners of DaVita Inc., reported an indirect sale of 182,980 shares of common stock on July 31, 2026 at $199.548 per share. After this sale, entities associated with Berkshire held 28,697,229 shares indirectly, primarily through Government Employees Insurance Company and certain pension plans, while Berkshire and Mr. Buffett disclaim beneficial ownership beyond any pecuniary interest.
DaVita Inc.'s Chief Legal & Public Affairs Officer, Kathleen Alyce Waters, reported two open-market sales of the company’s Common Stock. On June 15, 2026, she sold a total of 15,405 shares in two transactions: 6,455 shares at a weighted average price of $209.167 per share and 8,950 shares at a weighted average price of $207.844 per share. The filing notes price ranges for each sale and that one transaction was made under a Rule 10b5-1 trading plan adopted on March 16, 2026. After these sales, Waters continues to hold over 100,000 DaVita shares directly.
DaVita Inc. Chief Executive Officer Javier Rodriguez reported selling DaVita common stock in two open-market transactions. On June 15, 2026, he sold 30,000 shares of Common Stock at a weighted average price of $209.503 per share, in a price range from $209.000 to $210.140. On June 16, 2026, he sold an additional 39,407 shares at a weighted average price of $209.278 per share, within a range of $209.200 to $209.800. Following these sales, Rodriguez directly holds 840,408 shares of DaVita common stock.
DaVita Inc. director Phyllis R. Yale reported a bona fide gift of 5,038 shares of DaVita common stock. The shares were transferred at no stated value per share. After this gift, she directly holds 9,525 shares, indicating she retains a meaningful ongoing equity stake in the company.
Pullin Dennis W reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Dennis W. Pullin received a grant of 250 shares of Common Stock on May 15, 2026. The shares were awarded at no stated purchase price as equity compensation. After this award, he directly holds a total of 2,671 DaVita common shares.
Moore Gregory J. reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Gregory J. Moore received 250 shares of common stock as a grant on May 15, 2026, at no cost. This compensation-related award increased his directly held stake to 7,813 shares. The transaction reflects an equity grant rather than an open-market purchase or sale.
Schoppert Wendy Lee reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Wendy L. Schoppert reported a compensation-related stock grant and updated holdings. She received an award of 250 shares of DaVita common stock at $0.0000 per share, bringing her directly held common stock to 250 shares.
The filing also reports 3,637 shares of common stock held indirectly through the Wendy L. Schoppert Revocable Trust after the reported date. No open-market purchases or sales were reported in this filing.
Arway Pamela M reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Pamela M. Arway reported receiving a grant of 250 shares of DaVita common stock on May 15, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related stock award rather than an open-market purchase.
Following this grant, Arway directly holds 26,945 shares of DaVita common stock. This filing reflects a small, routine equity award that modestly increases her direct ownership stake in the company.
DaVita Inc. director Phyllis R. Yale received 250 shares of Common Stock as a grant or award, with no cash price per share reported. This non-derivative acquisition increased her direct holdings to 14,563 DaVita shares, reflecting routine equity-based compensation rather than an open-market purchase.
DESOER BARBARA J reported acquisition or exercise transactions in this Form 4 filing.
DAVITA INC. director Barbara J. Desoer reported a compensation-related stock grant. She received 250 shares of Common Stock as a grant or award at a stated price of $0.00 per share, bringing her directly held position to 250 shares.
The filing also shows 13,771 shares of Common Stock held indirectly through the “Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998,” reflecting additional beneficial ownership reported via a trust structure.
Schechter Adam H reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Adam H. Schechter received a grant of 250 shares of DaVita common stock on May 15, 2026. The shares were awarded at a price of $0.00 per share, indicating a compensation-related equity award rather than a market purchase. Following this grant, Schechter directly holds 5,692 shares of DaVita common stock.
DaVita Inc. director Jason M. Hollar reported receiving a grant of 250 shares of Common Stock on May 15, 2026. The shares were acquired at a reported price of $0.00 per share, indicating a compensation-related award rather than a market purchase. Following this grant, Hollar directly holds 6,605 shares of DaVita common stock. This filing reflects routine equity compensation and does not show any open-market buying or selling activity.
DaVita Inc.’s Chief Compliance Officer James O. Hearty reported an option-style exercise and subsequent stock sale. On May 14, 2026, he exercised 5,784 Stock Appreciation Rights at $110.63 per share, receiving common stock. Of these shares, 3,231 were withheld to pay the base price and 1,117 were withheld to cover tax obligations.
On May 15, 2026, he completed an open-market sale of 15,000 DaVita common shares at a weighted average price of $193.983, within a price range of $193.360–$199.840. Following these transactions, he directly owns 22,389 DaVita common shares.
DaVita Inc. Chief Operating Officer David Paul Maughan reported two open-market stock sales. On May 11, he sold 7,073 shares of DaVita common stock at a weighted average price of $199.149 per share. On May 12, he sold an additional 13,456 shares at a weighted average price of $199.254 per share. After these transactions, he directly owns 94,105 DaVita shares, so he continues to hold a substantial position in the company.
DaVita Inc.’s CFO and Treasurer Joel Ackerman reported an open-market sale of 51,471 shares of DaVita common stock. The transaction occurred on May 7, 2026 at a weighted average price of $192.099 per share, with individual sale prices ranging from $191.510 to $192.765. Following this sale, Ackerman directly holds 132,434 shares of DaVita common stock.
DaVita Inc. Chief Compliance Officer James O. Hearty reported an open-market sale of Common Stock. On May 6, 2026, he sold 2,184 shares at $174.87 per share. After this transaction, he directly owned 35,953 shares of DaVita common stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 15, 2025, indicating the trades were scheduled in advance.
DaVita Inc. insider filing shows a large share sale by Berkshire Hathaway–related entities. An entity associated with Berkshire completed an open-market sale of 1,220,376 shares of DaVita common stock at an average price of $149.8429 per share. After this transaction, Berkshire-associated holdings reported in the filing total 28,880,209 DaVita shares, held indirectly.
The filing explains that 13,906,601 of these shares are owned by Government Employees Insurance Company, a Berkshire subsidiary, and 14,973,608 shares are owned by pension plans of Berkshire subsidiaries. Berkshire and Warren E. Buffett disclaim beneficial ownership in certain shares except to the extent of any pecuniary interest.
Arway Pamela M reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Pamela M. Arway received an equity award of 332 shares of common stock, recorded at a grant price of $0.00 per share, as non-cash compensation. Following this grant, she directly owns 26,695 shares of DaVita common stock.
DaVita Inc. director Barbara J. Desoer received a stock award of 332 shares of common stock. The shares were acquired on March 15, 2026 as a grant with a stated price of $0.00 per share, indicating compensation rather than an open-market purchase.
Following this grant, Desoer directly holds 332 DaVita shares. She also has indirect ownership of 13,439 shares held through the “Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998,” giving her a combined reported position of 13,771 shares.
DaVita Inc. Chief Operating Officer David Paul Maughan reported equity compensation awards and related tax-withholding transactions. He received 14,351 stock appreciation rights tied to DaVita common stock at an exercise price of $150.7200 per share, expiring on March 15, 2031. He was also granted 5,308 shares of common stock as restricted stock units that are scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to award terms.
On the same date, DaVita withheld 5,339 shares and 7,768 shares of common stock to cover tax obligations on the vesting of earlier restricted stock unit grants from March 15, 2022 and March 15, 2023. These F-code dispositions are payments of tax liability, not open-market sales. After these transactions, Maughan directly owns 114,467 shares of DaVita common stock.
YALE PHYLLIS R reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Phyllis R. Yale received a grant of 332 shares of Common Stock, bringing her direct holdings to 14,313 shares. This Form 4 reflects a compensation-related share award, not an open-market purchase or sale, and represents a routine insider equity grant.
DaVita Inc. CEO Javier Rodriguez received new equity awards as part of his compensation. He was granted 20,900 shares of common stock and 56,506 stock appreciation rights, each tied to an equivalent number of underlying common shares at an exercise price of $150.72 per share.
The common stock award increases his direct holdings to 909,815 shares. Both the restricted stock units and the stock appreciation rights are scheduled to vest in two equal installments, 50% on March 15, 2029 and 50% on March 15, 2030, subject to the terms and conditions of the applicable award agreements.
Pullin Dennis W reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Dennis W. Pullin received a grant of 332 shares of common stock. The award was recorded at a price of $0.00 per share, indicating it was compensation rather than a market purchase. Following this grant, he directly holds 2,421 DaVita common shares.
Hollar Jason M. reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Jason M. Hollar received a grant of 332 shares of common stock. The award was recorded at a price of $0.00 per share as a compensation-related grant or award. Following this transaction, he directly owns a total of 6,355 DaVita common shares.
BERRY CHRISTOPHER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. Chief Accounting Officer Christopher Michael Berry reported receiving a grant of 3,649 shares of Common Stock as a compensation-related award, recorded at $0.00 per share rather than an open-market purchase.
According to the footnote, these are restricted stock units scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to the applicable award terms. After this award, Berry directly holds 19,640 shares of DaVita common stock.
DaVita Inc. CFO and Treasurer Joel Ackerman reported routine equity compensation and related tax-withholding transactions. He received a grant of 15,427 Stock Appreciation Rights tied to common stock at an exercise price of $150.72 per share, scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to award terms. He also acquired 5,706 shares of common stock as a stock award, with related restricted stock units vesting 50% on the same future dates. To cover tax obligations from the vesting of prior performance stock units and restricted stock units, 42,820 shares of common stock were withheld rather than sold in the open market, through three F-code transactions at a reference price of $150.72 per share. After these awards and tax withholdings, Ackerman directly holds 183,905 shares of DaVita common stock, reflecting ongoing equity-based compensation and associated tax settlements rather than discretionary open-market trades.
DaVita Inc. director Adam H. Schechter received a grant of 332 shares of common stock on March 15, 2026, as a non-cash award. The shares were acquired at a stated price of $0.00 per share and increased his directly held position to 5,442 shares of DaVita common stock.
Moore Gregory J. reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Gregory J. Moore received an equity award of 332 shares of Common Stock on March 15, 2026. The shares were granted at no cash cost per share, indicating a compensation-related award rather than an open-market purchase. Following this grant, Moore directly holds 7,563 DaVita shares.
DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported equity compensation grants and related tax withholdings. She received 8,610 stock appreciation rights tied to an equal number of common shares at an exercise price of $150.72 per share, scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to award terms. She also acquired 3,185 restricted stock units that are scheduled to vest on the same dates.
To cover tax obligations from the vesting of previously granted performance stock units and restricted stock units, 33,863 shares of common stock were withheld at $150.72 per share through several F-code transactions. Following these compensation-related grants and withholdings, Waters directly holds 124,599 shares of DaVita common stock.
DaVita Inc.’s Chief Compliance Officer, James O. Hearty, reported equity compensation and related tax withholding transactions. He received a grant of 3,050 stock appreciation rights tied to Common Stock at an exercise price of $150.72 per share, scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030.
He also acquired 1,128 shares of Common Stock as a share-based award, with the related restricted stock units scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030. In separate transactions, a total of 11,578 shares of Common Stock were withheld at $150.72 per share to satisfy tax withholding obligations upon vesting of performance stock units and earlier restricted stock units. After these compensation and tax-withholding entries, Hearty directly holds 38,137 shares of DaVita Common Stock.
DaVita Inc. director Wendy Lee Schoppert received a compensation-related stock award. On March 15, 2026, she acquired 332 shares of DaVita common stock with no purchase price, reported as a grant or similar award. Following this award, she directly held 332 shares and indirectly held 3,305 shares through the Wendy L. Schoppert Revocable Trust.
HEARTY JAMES O reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. reported that Chief Compliance Officer James O. Hearty received two non-derivative grants of common stock on March 10, 2026, comprising 1,756 shares and 20,533 shares, delivered upon satisfaction of criteria for earlier performance stock unit awards granted in 2022 and 2023 that are scheduled to vest 100% on March 15, 2026.
After these awards, he directly holds 48,587 shares of DaVita common stock.
ACKERMAN JOEL reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. insider filing shows equity awards to its CFO. Joel Ackerman, CFO and Treasurer of DaVita Inc., received two grants of common stock, covering 6,585 and 65,997 shares at no cost, as part of performance stock unit awards. These shares relate to performance stock units granted on March 15, 2022 and March 15, 2023, of which 100% will vest on March 15, 2026. Following these awards, he directly holds 221,019 shares of DaVita common stock.
DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported two stock awards of common shares. On March 10, 2026, she acquired 4,829 shares of DaVita common stock at a price of $0.00 per share and separately acquired 51,330 additional shares, also at $0.00 per share.
Footnotes explain these shares were received upon satisfaction of criteria for performance stock units granted on March 15, 2022 and March 15, 2023, with 100% of each award scheduled to vest on March 15, 2026. Following these acquisitions, Waters directly holds 155,277 shares of DaVita common stock.
DaVita Inc.’s Chief Legal & Public Affairs Officer, Kathleen Alyce Waters, reported several transactions on February 6, 2026. She exercised 8,079 Stock Appreciation Rights at an exercise price of $108.93, receiving the same number of common shares.
On the same date, she disposed of 5,898 shares of common stock at $149.22, and 817 shares were withheld to cover tax obligations related to the Stock Appreciation Rights exercise. After these transactions, she directly owned 99,118 shares of DaVita common stock.
DaVita Inc. CFO Joel Ackerman reported multiple equity transactions on February 6, 2026. He exercised 44,065 Stock Appreciation Rights at an exercise price of $108.93, receiving the same number of DaVita common shares. He then sold 32,168 common shares at $149.22 and had 5,100 shares withheld to cover tax obligations tied to the option exercise. After these transactions, he directly owned 148,437 DaVita common shares.
DaVita Inc. reported a large shareholder transaction involving entities affiliated with Berkshire Hathaway Inc. and Warren E. Buffett. On January 29, 2026, they reported the sale of 1,658,480 shares of DaVita common stock at $120.5561 per share, reported as indirectly owned.
After this sale, they reported indirect beneficial ownership of 30,100,585 DaVita shares. Of this total, 15,126,977 shares are owned by Government Employees Insurance Company, a Berkshire subsidiary. Another 14,973,608 shares are held by pension plans of Berkshire subsidiaries. Berkshire and Mr. Buffett may be deemed beneficial owners but expressly disclaim beneficial ownership except to the extent of any pecuniary interest.
DaVita Inc. reported an insider equity transaction by its Chief Compliance Officer. On 12/04/2025, the officer exercised stock appreciation rights covering 5,875 shares of DaVita common stock at a base price of $108.93 per share, receiving shares instead of cash. On the same date, 5,412 shares of common stock were disposed of at $118.25 per share, and an additional 203 shares were withheld at $118.25 per share to cover tax obligations related to the exercise.
After these transactions, the officer beneficially owned 26,298 shares of DaVita common stock in direct form. The stock appreciation rights used in this exercise were originally granted on March 15, 2021 and vested in two equal installments on March 15, 2024 and March 15, 2025.
DaVita Inc. (DVA) director reports stock acquisition. A director of DaVita Inc. reported acquiring 411 shares of the company’s common stock on 11/15/2025 in a transaction priced at $0 per share, as disclosed on a Form 4. Following this transaction, the director beneficially owns 13,981 shares of DaVita common stock, held directly.
DaVita Inc. director reports a small stock acquisition. A DaVita Inc. (DVA) director filed a Form 4 reporting the acquisition of 411 shares of common stock on 11/15/2025 at a reported price of $0 per share. After this transaction, the director holds 411 shares as a direct owner and 2,894 shares as an indirect owner through the Wendy L. Schoppert Revocable Trust. No derivative securities were reported in this filing.
DaVita Inc. director reports a small stock acquisition. A director of DaVita Inc. (DVA) acquired 411 shares of common stock on 11/15/2025 at a reported price of $0 per share, indicating this was likely an equity grant rather than an open-market purchase. Following this transaction, the director beneficially owns 5,110 shares of DaVita common stock, held directly. No derivative securities such as options or warrants are reported as acquired or disposed of in this filing.
A DaVita Inc. (DVA) director reported acquiring 411 shares of common stock on 11/15/2025 at a stated price of $0, indicating this was likely a stock grant rather than an open-market purchase. Following this transaction, the director beneficially owns 2,089 DaVita shares, held in direct ownership. This is a routine insider ownership update showing a modest increase in the director’s equity stake.